Literature DB >> 8181804

Epithelioid benign fibrous histiocytoma of skin: clinico-pathological analysis of 20 cases of a poorly known variant.

C Singh Gomez1, E Calonje, C D Fletcher.   

Abstract

Twenty new cases of epithelioid fibrous histiocytoma, a distinctive but poorly recognized variant of cutaneous benign fibrous histiocytoma are described. Twelve patients were male and eight were female. The age of the patients ranged from 7 to 80 years (median 40 years). Six lesion arose on the lower limb, five on the upper limb, three around the shoulder, two on the abdomen and one each on the eyelid, inner canthus and anal margin. In one case the age and site were not stated. All lesions presented as a solitary, polypoid or slightly raised cutaneous nodule, ranging in size from 0.5 cm to 2 cm in greatest diameter. Follow-up in 14 cases (mean 22.7 months) revealed local recurrence after 42 months in one case. Histologically, the more polypoid tumours were characterized by an epidermal collarette. In all lesions prominent polygonal or rounded epithelioid cells with abundant eosinophilic cytoplasm, a vesicular nucleus and small eosinophilic nucleoli accounted for at least 50% of the tumour cell population. Individual cells were separated by somewhat hyalinized collagen, containing prominent blood vessels and a sparse mononuclear inflammatory cell infiltrate. The edge of the lesions, especially those that were non-polypoid, often showed more typical features of ordinary fibrous histiocytoma. The main differential diagnosis is with other cutaneous epithelioid neoplasms, especially Spitz naevus.

Entities:  

Mesh:

Year:  1994        PMID: 8181804     DOI: 10.1111/j.1365-2559.1994.tb01290.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  8 in total

1.  ALK rearrangement and overexpression in epithelioid fibrous histiocytoma.

Authors:  Leona A Doyle; Adrián Mariño-Enriquez; Christopher D M Fletcher; Jason L Hornick
Journal:  Mod Pathol       Date:  2015-04-10       Impact factor: 7.842

2.  Epithelioid fibrous histiocytoma: molecular characterization of ALK fusion partners in 23 cases.

Authors:  Brendan C Dickson; David Swanson; George S Charames; Christopher Dm Fletcher; Jason L Hornick
Journal:  Mod Pathol       Date:  2018-01-12       Impact factor: 7.842

3.  Gene fusion detection in formalin-fixed paraffin-embedded benign fibrous histiocytomas using fluorescence in situ hybridization and RNA sequencing.

Authors:  Charles Walther; Jakob Hofvander; Jenny Nilsson; Linda Magnusson; Henryk A Domanski; David Gisselsson; Johnbosco Tayebwa; Leona A Doyle; Christopher D M Fletcher; Fredrik Mertens
Journal:  Lab Invest       Date:  2015-06-29       Impact factor: 5.662

Review 4.  Problematic pigmented lesions: approach to diagnosis.

Authors:  S L Edwards; K Blessing
Journal:  J Clin Pathol       Date:  2000-06       Impact factor: 3.411

5.  Superficial ALK-rearranged myxoid spindle cell neoplasm: a cutaneous soft tissue tumor with distinctive morphology and immunophenotypic profile.

Authors:  Steven D Billings; Jennifer S Ko; Josephine K Dermawan; Elizabeth M Azzato; John R Goldblum; Brian P Rubin
Journal:  Mod Pathol       Date:  2021-06-04       Impact factor: 7.842

6.  A sessile nodule with vascular appearance.

Authors:  Nicolás Silvestre-Torner; Jorge Román-Sainz; Fernando Gruber-Velasco; Belén Romero-Jiménez; Adrián Imbernón-Moya; María Dorado-Fernández; Adrián Nogales-Moro; Fernando Burgos-Lázaro
Journal:  JAAD Case Rep       Date:  2022-03-26

7.  Cutaneous benign epithelioid peripheral nerve sheath tumour: a rare entity.

Authors:  Anuradha Ck Rao; Lakshmi Rao; G Chennakeshav Rao; Vasudeva R Somayagi
Journal:  Indian J Dermatol       Date:  2013-09       Impact factor: 1.494

8.  Variants of dermatofibroma--a histopathological study.

Authors:  João Vítor Pina Alves; Diogo Miguel Matos; Hugo Frederico Barreiros; Elvira Augusta Felgueira Leonardo Fernandes Bártolo
Journal:  An Bras Dermatol       Date:  2014 May-Jun       Impact factor: 1.896

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.